• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SLC37A4 - 先天性糖基化障碍:葡萄糖 - 6 - 磷酸转运体在高尔基体的定位错误导致一种新的先天性糖基化障碍。

SLC37A4-CDG: Mislocalization of the glucose-6-phosphate transporter to the Golgi causes a new congenital disorder of glycosylation.

作者信息

Marquardt Thorsten, Bzduch Vladimir, Hogrebe Max, Rust Stephan, Reunert Janine, Grüneberg Marianne, Park Julien, Callewaert Nico, Lachmann Robin, Wada Yoshinao, Engel Thomas

机构信息

University Children's Hospital Münster, Department of General Pediatrics, Münster, Germany.

Comenius University, National Institute of Children's Diseases, Department of Paediatrics, Limbová 1, 83340 Bratislava, Slovakia.

出版信息

Mol Genet Metab Rep. 2020 Aug 21;25:100636. doi: 10.1016/j.ymgmr.2020.100636. eCollection 2020 Dec.

DOI:10.1016/j.ymgmr.2020.100636
PMID:32884905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7451446/
Abstract

Loss-of-function of the glucose-6-phosphate transporter is caused by biallelic mutations in SLC37A4 and leads to glycogen storage disease Ib. Here we describe a second disease caused by a single dominant mutation in the same gene. The mutation abolishes the ER retention signal of the transporter and generates a weak Golgi retention signal. Intracellular mislocalization of the transporter leads to a congenital disorder of glycosylation instead of glycogen storage disease.

摘要

葡萄糖-6-磷酸转运体的功能丧失是由SLC37A4基因的双等位基因突变引起的,可导致糖原贮积病Ib型。在此,我们描述了由同一基因的单一显性突变引起的第二种疾病。该突变消除了转运体的内质网保留信号,并产生了一个较弱的高尔基体保留信号。转运体的细胞内定位错误导致糖基化先天性疾病,而非糖原贮积病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b3/7451446/6f744f1d846e/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b3/7451446/af57e4efde75/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b3/7451446/b8203b7e3b6a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b3/7451446/8cd5160e3f79/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b3/7451446/6f744f1d846e/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b3/7451446/af57e4efde75/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b3/7451446/b8203b7e3b6a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b3/7451446/8cd5160e3f79/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b3/7451446/6f744f1d846e/gr4.jpg

相似文献

1
SLC37A4-CDG: Mislocalization of the glucose-6-phosphate transporter to the Golgi causes a new congenital disorder of glycosylation.SLC37A4 - 先天性糖基化障碍:葡萄糖 - 6 - 磷酸转运体在高尔基体的定位错误导致一种新的先天性糖基化障碍。
Mol Genet Metab Rep. 2020 Aug 21;25:100636. doi: 10.1016/j.ymgmr.2020.100636. eCollection 2020 Dec.
2
SLC37A4-CDG: Second patient.SLC37A4 - 先天性糖基化障碍:第二位患者。
JIMD Rep. 2021 Jan 6;58(1):122-128. doi: 10.1002/jmd2.12195. eCollection 2021 Mar.
3
SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathy.SLC37A4-CDG:一种新兴的伴发严重凝血障碍的糖基化先天性疾病的新生化见解。
Clin Chim Acta. 2021 Oct;521:104-106. doi: 10.1016/j.cca.2021.07.005. Epub 2021 Jul 8.
4
A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction.SLC37A4 中的突变导致一种显性遗传的糖基化先天性疾病,其特征为肝功能障碍。
Am J Hum Genet. 2021 Jun 3;108(6):1040-1052. doi: 10.1016/j.ajhg.2021.04.013. Epub 2021 May 7.
5
CRISPR/Cas9 genome editing of SLC37A4 gene elucidates the role of molecular markers of endoplasmic reticulum stress and apoptosis in renal involvement in glycogen storage disease type Ib.CRISPR/Cas9 基因编辑 SLC37A4 基因阐明了内质网应激和细胞凋亡的分子标志物在糖原贮积病 Ib 型肾受累中的作用。
Gene. 2019 Jun 30;703:17-25. doi: 10.1016/j.gene.2019.04.002. Epub 2019 Apr 3.
6
Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b.突尼斯1b型糖原贮积症患者中导致葡萄糖-6-磷酸转运体缺陷的突变鉴定。
Diabetol Metab Syndr. 2023 Apr 28;15(1):86. doi: 10.1186/s13098-023-01065-2.
7
[Mutation in the SLC37A4 gene of glycogen storage disease type Ib in 15 families of the mainland of China].[中国大陆15个家庭中I型糖原贮积病的SLC37A4基因突变]
Zhonghua Er Ke Za Zhi. 2011 Mar;49(3):203-8.
8
[Gene mutations and clinical manifestations in children with glycogen storage disease type Ib].[1b型糖原贮积病患儿的基因突变与临床表现]
Zhongguo Dang Dai Er Ke Za Zhi. 2013 Aug;15(8):661-5.
9
Molecular biology and gene therapy for glycogen storage disease type Ib.糖原贮积病 Ib 型的分子生物学与基因治疗。
J Inherit Metab Dis. 2018 Nov;41(6):1007-1014. doi: 10.1007/s10545-018-0180-5. Epub 2018 Apr 16.
10
Glycogen storage disease type 1b: an early onset severe phenotype associated with a novel mutation (IVS4) in the glucose 6-phosphate translocase (SLC37A4) gene in a Turkish patient.1b型糖原贮积病:一名土耳其患者中与葡萄糖6-磷酸转运体(SLC37A4)基因新突变(IVS4)相关的早发严重表型。
Genet Couns. 2014;25(4):389-94.

引用本文的文献

1
SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathy.SLC37A4-CDG:一种新兴的伴发严重凝血障碍的糖基化先天性疾病的新生化见解。
Clin Chim Acta. 2021 Oct;521:104-106. doi: 10.1016/j.cca.2021.07.005. Epub 2021 Jul 8.
2
A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction.SLC37A4 中的突变导致一种显性遗传的糖基化先天性疾病,其特征为肝功能障碍。
Am J Hum Genet. 2021 Jun 3;108(6):1040-1052. doi: 10.1016/j.ajhg.2021.04.013. Epub 2021 May 7.
3
SLC37A4-CDG: Second patient.

本文引用的文献

1
Limitations of galactose therapy in phosphoglucomutase 1 deficiency.半乳糖疗法在磷酸葡萄糖变位酶1缺乏症中的局限性。
Mol Genet Metab Rep. 2017 Jul 31;13:33-40. doi: 10.1016/j.ymgmr.2017.07.010. eCollection 2017 Dec.
2
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.I型糖原贮积病:葡萄糖-6-磷酸酶/葡萄糖-6-磷酸转运体复合物的紊乱
J Inherit Metab Dis. 2015 May;38(3):511-9. doi: 10.1007/s10545-014-9772-x. Epub 2014 Oct 7.
3
Retention mechanisms for ER and Golgi membrane proteins.
SLC37A4 - 先天性糖基化障碍:第二位患者。
JIMD Rep. 2021 Jan 6;58(1):122-128. doi: 10.1002/jmd2.12195. eCollection 2021 Mar.
4
Novel Insights into Selected Disease-Causing Mutations within the Gene Encoding the CMP-Sialic Acid Transporter.新型疾病相关突变的深入研究:编码 CMP-唾液酸转运蛋白的基因
Int J Mol Sci. 2020 Dec 30;22(1):304. doi: 10.3390/ijms22010304.
内质网和高尔基体膜蛋白的滞留机制。
Trends Plant Sci. 2014 Aug;19(8):508-15. doi: 10.1016/j.tplants.2014.04.004. Epub 2014 Apr 30.
4
The SLC37 family of sugar-phosphate/phosphate exchangers.糖磷酸/磷酸交换体的SLC37家族。
Curr Top Membr. 2014;73:357-82. doi: 10.1016/B978-0-12-800223-0.00010-4.
5
Mechanisms of protein retention in the Golgi.蛋白质在高尔基体中滞留的机制。
Cold Spring Harb Perspect Biol. 2011 Aug 1;3(8):a005264. doi: 10.1101/cshperspect.a005264.
6
Expression and functional characterization of ABCG1 splice variant ABCG1(666).ABCG1剪接变体ABCG1(666)的表达及功能特性
FEBS Lett. 2006 Aug 7;580(18):4551-9. doi: 10.1016/j.febslet.2006.07.006. Epub 2006 Jul 13.
7
Endoplasmic reticulum export of glycosyltransferases depends on interaction of a cytoplasmic dibasic motif with Sar1.糖基转移酶的内质网输出取决于细胞质双碱性基序与Sar1的相互作用。
Mol Biol Cell. 2003 Sep;14(9):3753-66. doi: 10.1091/mbc.e03-02-0101. Epub 2003 May 18.
8
Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.糖原贮积病Ib型中葡萄糖-6-磷酸转运体的结构-功能分析
Hum Mol Genet. 2002 Dec 1;11(25):3199-207. doi: 10.1093/hmg/11.25.3199.
9
Structural requirements for the stability and microsomal transport activity of the human glucose 6-phosphate transporter.人葡萄糖-6-磷酸转运体稳定性及微粒体转运活性的结构要求
J Biol Chem. 2000 Nov 3;275(44):34280-6. doi: 10.1074/jbc.M006439200.
10
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a.在几乎所有非a型糖原贮积病I型病例中,假定的葡萄糖6-磷酸转运酶基因都发生了突变。
Eur J Hum Genet. 1999 Sep;7(6):717-23. doi: 10.1038/sj.ejhg.5200366.